Gonadotropin levels at the start of ovarian stimulation predict normal fertilization after hCG re-trigger in GnRH antagonist cycles

被引:0
|
作者
Kitasaka, Hiroya [1 ]
Tokoro, Mikiko [1 ,2 ]
Kojima, Masae [1 ]
Fukunaga, Noritaka [1 ,2 ]
Asada, Yoshimasa [1 ,2 ]
机构
[1] Asada Ladies Clin, Nagoya, Aichi, Japan
[2] Asada Inst Reprod Med, Kasugai, Aichi, Japan
关键词
controlled ovarian stimulation; gonadotropin‐ releasing hormone antagonist protocol; releasing hormone agonist trigger; luteinizing hormone surge; oocyte maturation; INTRACYTOPLASMIC SPERM INJECTION; ENDOTHELIAL GROWTH-FACTOR; HORMONE AGONIST TRIGGER; OOCYTE MATURATION; HYPERSTIMULATION SYNDROME; MENSTRUAL-CYCLE; CORPUS-LUTEUM; EXPRESSION; FAILURE; ICSI;
D O I
10.1002/rmb2.12359
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose To assess the appropriateness of human chorionic gonadotropin (hCG) re-trigger in poor responders to gonadotropin-releasing hormone agonist (GnRHa) trigger in controlled ovarian stimulation (COS) cycles. Methods The 2251 cycles in 2251 patients triggered with GnRHa for oocyte stimulation, with or without requiring hCG re-trigger between 2013 and 2018, were retrospectively analyzed to compare gonadotropin levels at the start of COS and the rate of normal fertilization between the re-trigger and non-re-trigger group. Furthermore, patients in the re-trigger group were stratified by the rate of normal fertilization (good: >= 60% or poor: <60%) to compare patient demographics, hormone profiles, and clinical outcome between the subgroups. Results In the re-trigger group, FSH and LH levels at the start of COS were significantly lower in the good fertilization group than in the poor fertilization group (P < .01). Receiver operating characteristic curves identified cutoff values of the FSH and LH levels of 1.30 and 0.35 mIU/mL, respectively, for predicting >= 60% normal fertilization. Conclusion Gonadotropin levels at the start of COS are predictors of response to GnRHa trigger and hCG re-trigger necessity, and may serve as indicators to help clinicians appropriately choose hCG re-trigger rather than abandoning the cycles or continuing the first oocyte aspiration attempt.
引用
收藏
页码:96 / 107
页数:12
相关论文
共 50 条
  • [21] Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles
    Albeitawi, Soha
    Abu Marar, Ehab
    Al Reshoud, Firas
    Hamadneh, Jehan
    Hamza, Rami
    Alhasan, Ghassan
    Omeish, Haya
    Vigano, Paola
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2022, 26 (01): : 28 - 32
  • [22] DUAL TRIGGER USING RECOMBINANT HCG AND GONADOTROPIN-RELEASING HORMONE AGONIST IMPROVE OOCYTE QUALITY AND EMBRYO GRADING FOR NORMAL RESPONDERS IN GNRH ANTAGONIST CYCLES: RANDOMIZED CONTROLLED TRIAL.
    Abdelaleem, Ahmed Ali
    Ali, Shymaa
    Abbas, Ahmed M.
    Farghaly, Tarek
    Elsenosy, Elwany
    Sayed, Gamal
    FERTILITY AND STERILITY, 2019, 112 (03) : E205 - E206
  • [23] Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all'' approach in GnRH antagonist protocol
    Fatemi, Human Mousavi
    Popovic-Todorovic, Biljana
    Humaidan, Peter
    Kol, Shahar
    Banker, Manish
    Devroey, Paul
    Antonio Garcia-Velasco, Juan
    FERTILITY AND STERILITY, 2014, 101 (04) : 1008 - 1011
  • [24] Single dose nasal spray of gonadotropin releasing hormone (GnRH) agonist effectively matures oocytes for in vitro fertilization in an ovarian stimulation protocol using clomiphene citrate, gonadotropin, and GnRH antagonist.
    Goto, T
    Oka, C
    Tomiyama, T
    Mukaida, T
    Takahashi, K
    FERTILITY AND STERILITY, 2003, 80 : S6 - S6
  • [25] Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles
    Urbancsek, J
    Hauzman, EE
    Murber, A
    Lagarde, AR
    Rabe, T
    Papp, Z
    Strowitzki, T
    GYNECOLOGICAL ENDOCRINOLOGY, 2005, 21 (01) : 38 - 44
  • [26] Effect of progesterone concentration on hCG trigger day on clinical outcomes after high-quality single blastocyst transfer in GnRH antagonist cycles
    Jia, Nan
    Xu, Jianing
    Song, Bingbing
    Hao, Haoying
    Li, Meng
    Zhang, Cuilian
    Zhang, Shaodi
    FRONTIERS IN MEDICINE, 2024, 11
  • [27] Can serve Medroxiprogesterone acetate (MPA) as pituitary suppressor instead of GnRH antagonist during ovarian stimulation (OS) in oocyte donation (OD) cycles trigger with GnRH agonist?
    Giles, I.
    Alama, P.
    Gamiz, P.
    Vidal, C.
    Badia, P.
    Bosch, E.
    HUMAN REPRODUCTION, 2020, 35 : 5 - 5
  • [28] EFFECT OF TRIGGER-TO-OOCYTE COLLECTION INTERVAL ON COLLECTED OOCYTE COUNT IN PROGESTIN-PRIMED OVARIAN STIMULATION (PPOS) AND GNRH ANTAGONIST CYCLES
    Cakar, Aysu
    Yildiz, Sule
    Turkgeldi, Engin
    Keles, Ipek
    Bozdag, Gurkan
    Kalafat, Erkan
    Ata, Baris
    FERTILITY AND STERILITY, 2023, 120 (04) : E112 - E112
  • [29] LOW SERUM HUMAN CHORIONIC GONADOTROPIN (hCG) LEVELS AFTER TRIGGER INJECTION FOR IN VITRO FERTILIZATION (IVF): ASSOCIATED FACTORS, IMPACT, AND PREVENTION
    Prinz, D. M.
    Seager, C. K.
    Ahmady, A.
    Weil, S.
    Liu, J. H.
    Hurd, W. W.
    FERTILITY AND STERILITY, 2011, 96 (03) : S191 - S191
  • [30] DETERMINING THE OPTIMAL FOLLICLE SIZE AT TRIGGER IN PATIENTS UNDERGOING OVARIAN STIMULATION WITH A CLOMIPHENE CITRATE PLUS GONADOTROPIN ANTAGONIST PROTOCOL FOR IN VITRO FERTILIZATION.
    Shah, Nirali J.
    Romanski, Phillip A.
    Bortoletto, Pietro
    Rosenwaks, Zev
    Kligman, Isaac
    FERTILITY AND STERILITY, 2020, 114 (03) : E306 - E306